Foley Hoag LLP

WHEN

May 20, 2008 6:30 PM - 9:30 PM

WHERE

Emerging Enterprise Center at Foley Hoag
Bay Colony Corporate Center, North Entrance
1000 Winter Street – Suite 4000
Waltham, MA 02451

Map

SUMMARY

For our May 20^th event, the EntreTech Forum takes a break from its industry-specific theme and refocuses on the issue of how new ventures of all types are funded, starting from their embryonic stages in academic research labs to fully-realized commercialization.  In particular, the EntreTech Forum’s panelists will help the audience understand the funding value-chain from the perspective of the funding sources themselves.  Panelists have been brought together from seed-level government grants and angel funding through venture capital sources all the way to mature investment banking and commercial banking applications.  This forum event will break new ground in bringing together representatives of each funding source all at once.  For all of those individuals interested in understanding the inputs, outputs, incentives, and issues from the standpoint of venture funding sources, this is a must-attend event.

WHEN

May 21, 2008 7:30 AM - 12:00 PM

WHERE

Emerging Enterprise Center at Foley Hoag
Bay Colony Corporate Center, North Entrance
1000 Winter Street – Suite 4000
Waltham, MA 02451

Map

SUMMARY

You're invited to attend a session designed by investment bankers, communications professionals, investors and legal professionals who work day in and day out with small and microcap companies that will teach you effective strategies to better navigate the investment markets and secure both the interest and financial support you need to achieve your business goals. 

WHEN

May 29 7:30 AM - May 30, 2008 5:00 PM

WHERE

Hotel Whitcomb
1231 Market Street
San Francisco, CA 94588

Map

SUMMARY

The approval process…pre-approval concerns…product labeling… clinical trials…adverse events reports…patent concerns…exclusivity… All are critical aspects in the commercialization process for drugs, biologics, and devices that are governed by FDA law and regulation. Plus, the FDA Amendments Act of 2007 (FDAAA) is one of the most comprehensive revisions of FDA law in decades. And recent court cases and high-profile trials concerning FDA-regulated products have made it clear that it is essential for attorneys who do not have regulatory practices — but who do deal with FDA-regulated products — to have a familiarity with these concepts. The same can be said of securities experts and business executives in the life sciences arena.

Products liability and patent litigation concerning these products often hinges on what happened during the pre-approval, approval, or post-approval periods.

However, many products liability lawyers, patent counsel, and business and investment experts — despite their tenure in working with FDA-regulated products — are not well-versed in the essentials of the approval process and the regulatory hurdles of the post-approval period.

ACI’s FDA Boot Camp has been designed to give products and patent litigators, as well as patent prosecutors and life sciences investment and securities experts, a strong working knowledge of core FDA competencies, including the nuances of FDAAA.

WHEN

June 4, 2008 6:00 PM - 9:00 PM

WHERE

Emerging Enterprise Center at Foley Hoag
Bay Colony Corporate Center, North Entrance
1000 Winter Street – Suite 4000
Waltham, MA 02451

Map

SUMMARY

Advances in neuroscience are revolutionizing our understanding of the human brain. The national economic burden from neurological disorders in the US alone is estimated at $500 billion. However, new research and new products are yielding a vastly improved understanding of brain disease and injuries, human cognition and behavior, creating an unprecedented ability to treat and heal those in need.

WHEN

June 10, 2008 7:30 AM - 9:30 AM

WHERE

Emerging Enterprise Center at Foley Hoag
Bay Colony Corporate Center, North Entrance
1000 Winter Street – Suite 4000
Waltham, MA 02451

Map

SUMMARY

Seasoned entrepreneurs know that the planning for the next round starts the day you close your last round. While entrepreneurs can’t control the economy and the effects it may have on valuation, you can insure that you manage to milestones and build enterprise value. This panel of experienced entrepreneurs and investors will provide insight and guidance on key strategies that can help insure you increase your valuation each round and avoid unnecessary dilution. 

Moderator: Carl Stjernfeldt, General Partner, Castile Ventures

Confirmed panelists include:

• Ted Morgan, CEO and Founder, Skyhook Wireless
• Jonathan Seelig, Managing Director, Globespan Capital Partners

WHEN

June 17 7:00 AM - June 20, 2008 12:30 PM

WHERE

San Diego Convention Center
San Diego, CA

SUMMARY

BIO 2008 will be held at the San Diego Convention Center, San Diego, CA.  Click here for the BIO 2008 event brochure. 

To learn more about Foley Hoag's life sciences expertise, please visit us at our booth and/or attend one of the panel discussions in which our attorneys are involved.

Wednesday, June 18th
Program:  A Case Study of a Biotechnology-related Action Before the International Trade Commission
Time:  10:15 AM - 11:45 AM
Partner DeAnn Smith will be participating in this Intellectual Property/Legal track panel.

Thursday, June 19th
Program:  Regulating the Future of Diagnostics
Time:  10:30 AM - 12:00 PM
Partner Paul Kim will be participating in this Policy track panel. 

Program:  Virtues and Vices of Virtual Biotechnology Companies
Time:  4:00 PM - 5:30 PM
Partner Jeffrey Quillen will be participating in this Business Development track panel.

WHEN

June 18, 2008 2:00 PM - 3:30 PM

WHERE

San Diego Convention Center
San Diego, CA

SUMMARY

A case study of an International Trade Commission Section 337 investigation will be presented. The session will provide a comprehensive overview of fast-paced 337 proceedings before the ITC, as well as the unique rules applicable to these investigations. Session participants will hear directly from experienced 337 litigation counsel from the United States and China. A hypothetical case study will walk session participants through a biotechnology-related proceeding, from the filing of the complaint to final adjudication.

WHEN

September 6 8:30 AM - September 11, 2008 1:00 PM

WHERE

Boston Convention and Exhibition Center
415 Summer Street
Boston, MA 02210

Map

SUMMARY

AIPPI is a French acronym for the International Association for the Protection of Intellectual Property. It is over 100 years old, dating back to the treaty of Paris. It holds an international congress every other year. The congress is the largest meeting of general intellectual property attorneys in the world. The Boston meeting will be AIPPI's 41st congress and the first one in the United States since 1975. We expect over 2,000 participants from around the world, plus another 1,000 or more accompanying persons. The attendees will include both outside intellectual property counsel and corporate intellectual property counsel from companies such as Microsoft, Rohm & Haas, Yahoo!, General Electric, SAP, and Sun Microsystems.